Summary by Moomoo AI
On December 29, 2023, Baillie Gifford & Co, a Scottish partnership, filed an amended Schedule 13G/A with the SEC, indicating a significant ownership stake in Ginkgo Bioworks Holdings, Inc. The filing revealed that Baillie Gifford & Co holds 236,292,183 shares of Ginkgo Bioworks, representing 14.59% of the company's Class A Common Stock. The shares are held on behalf of various investment advisory clients, including Scottish Mortgage Investment Trust PLC, which is managed by Baillie Gifford & Co Limited, a subsidiary of Baillie Gifford & Co. The filing, which falls under Rule 13d-1(b), asserts that the shares were acquired in the ordinary course of business and not with the intent to change or influence the control of Ginkgo Bioworks. The compliance manager of Baillie Gifford & Co, Grant Meikle, signed the statement on January 16, 2024, certifying the accuracy of the information provided.